Jerrold Sendrow
Direttore/Membro del Consiglio presso VIRPAX PHARMACEUTICALS, INC.
Patrimonio netto: 630 $ in data 31/05/2024
Profilo
Jerrold Sendrow is an Independent Director at Virpax Pharmaceuticals, Inc. He previously worked as a Director at Scilex Pharmaceuticals, Inc. and held positions at Peat Marwick Mitchell & Co., Touche Ross & Co., and Touche Ross & Co. (Australia).
He completed his undergraduate education at Adelphi University and Baruch College.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
03/06/2024 | 900 ( 0.03% ) | 630 $ | 31/05/2024 |
Posizioni attive di Jerrold Sendrow
Società | Posizione | Inizio |
---|---|---|
VIRPAX PHARMACEUTICALS, INC. | Direttore/Membro del Consiglio | 01/01/2017 |
Precedenti posizioni note di Jerrold Sendrow
Società | Posizione | Fine |
---|---|---|
SCILEX Pharmaceuticals, Inc.
SCILEX Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology SCILEX Pharmaceuticals, Inc. engages in the development and commercialization of pharmaceutical products. It acquires late-stage clinical development and sales and marketing of generic and branded generic products. Its product includes ZTlido. The company was founded by Anthony P. Mack and William Pedranti in 2011 and is headquartered in Berwyn, PA. | Direttore/Membro del Consiglio | 01/11/2016 |
Touche Ross & Co. | Comptroller/Controller/Auditor | - |
Touche Ross & Co. (Australia) | Comptroller/Controller/Auditor | - |
Peat Marwick Mitchell & Co. | Comptroller/Controller/Auditor | - |
Formazione di Jerrold Sendrow
Baruch College | Undergraduate Degree |
Adelphi University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
VIRPAX PHARMACEUTICALS, INC. | Health Technology |
Aziende private | 4 |
---|---|
SCILEX Pharmaceuticals, Inc.
SCILEX Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology SCILEX Pharmaceuticals, Inc. engages in the development and commercialization of pharmaceutical products. It acquires late-stage clinical development and sales and marketing of generic and branded generic products. Its product includes ZTlido. The company was founded by Anthony P. Mack and William Pedranti in 2011 and is headquartered in Berwyn, PA. | Health Technology |
Peat Marwick Mitchell & Co. | Commercial Services |
Touche Ross & Co. (Australia) | |
Touche Ross & Co. | Commercial Services |
- Borsa valori
- Insiders
- Jerrold Sendrow